AAAAI 2017
Omalizumab Associated with Reduced Allergic Asthma Exacerbations, Hospitalizations
Omalizumab therapy was associated with reduced exacerbation and hospitalization rates in US clinics, according to findings from the prospective multicenter observational registry PROSPERO study